MoneyWorks4Me

Ind-Swift Laboratories informs about disclosure

18 Dec 2025 Evaluate
Ind-Swift Laboratories has informed that the exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rishav Mehta, Ishav Mehta & Daksh Mehta.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..